| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Short-term marketable securities | - | - | 1,796,500 | 1,871,100 |
| Cash and cash equivalents | 1,835,700 | 1,159,000 | 904,900 | 621,200 |
| Short-term marketable securities | 1,486,400 | 1,770,300 | - | - |
| Accounts receivable, net | 1,109,600 | 1,348,800 | 1,155,200 | 1,002,000 |
| Inventory | 604,100 | 570,700 | 538,200 | 586,300 |
| Prepaid and other current assets | 183,700 | 181,400 | 159,000 | 182,200 |
| Total current assets | 5,219,500 | 5,030,200 | 4,553,800 | 4,262,800 |
| Property and equipment, net | 1,471,300 | 1,457,300 | 1,364,700 | 1,318,800 |
| Operating lease right-of-use assets | 54,000 | 56,400 | 59,100 | 67,500 |
| Goodwill | 24,100 | 24,100 | 23,100 | 23,800 |
| Intangibles, net | 79,000 | 87,200 | 95,200 | 106,200 |
| Deferred tax assets | 375,600 | 496,300 | 487,300 | 486,500 |
| Other assets | 276,500 | 175,500 | 168,500 | 88,200 |
| Total assets | 7,500,000 | 7,327,000 | 6,751,700 | 6,353,800 |
| Accounts payable and accrued liabilities | 1,932,400 | 1,943,800 | 1,690,600 | 1,592,500 |
| Accrued payroll and related expenses | 170,200 | 129,300 | 110,800 | 105,800 |
| Current portion of long-term senior convertible notes | 1,206,900 | 1,206,100 | 1,205,300 | - |
| Short-term operating lease liabilities | 23,600 | 23,400 | 22,600 | 22,300 |
| Deferred revenue | 2,900 | 6,100 | 7,800 | 13,900 |
| Total current liabilities | 3,336,000 | 3,308,700 | 3,037,100 | 1,734,500 |
| Long-term senior convertible notes | 1,239,900 | 1,238,900 | 1,238,000 | 2,439,600 |
| Long-term operating lease liabilities | 50,600 | 54,700 | 59,700 | 71,100 |
| Other long-term liabilities | 147,400 | 151,600 | 150,300 | 129,600 |
| Total liabilities | 4,773,900 | 4,753,900 | 4,485,100 | 4,374,800 |
| Common stock, 0.001 par value, 800.0 million shares authorized 410.6 million and 390.0 million shares issued and outstanding, respectively, at september30, 2025 and 408.9 million and 390.7 million shares issued and outstanding, respectively, at december31, 2024 | 400 | - | 400 | 400 |
| Additional paid-in capital | 2,246,500 | 2,187,500 | 2,142,200 | 2,050,500 |
| Accumulated other comprehensive income (loss) | 81,500 | 83,600 | 2,200 | 63,400 |
| Retained earnings | 2,166,600 | 1,882,800 | 1,703,000 | 1,445,900 |
| Treasury stock, at cost 20.6 million shares at september30, 2025 and 18.2 million shares at december31, 2024 | 1,768,900 | 1,581,200 | 1,581,200 | 1,581,200 |
| Total stockholders equity | 2,726,100 | 2,573,100 | 2,266,600 | 1,979,000 |
| Total liabilities and stockholders equity | 7,500,000 | 7,327,000 | 6,751,700 | 6,353,800 |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)